Suppressors of cytokine signaling regulate Fc receptor signaling and cell activation during immune renal injury

Journal of Immunology

Volumn 172, Issue 11, 2004, Pages 6969-6977

  Gómez Guerrero, Carmen ^a,d   López Franco, Oscar ^a   Sanjuán, Guillermo ^a   Hernández Vargas, Purificación ^a   Suzuki, Yusuke ^b   Ortiz Muñoz, Guadalupe ^a   Blanco, Julia ^c   Egido, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; PROTEIN SH2; PROTEIN TYROSINE KINASE; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE COMPLEX NEPHRITIS; KIDNEY INJURY; KNOCKOUT MOUSE; MESANGIUM CELL; MONOCYTE; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEINURIA; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

EID: 2442686675     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.11.6969     Document Type: Article

References (45)

1. Starr, R., T. A. Wilson, E. M. Viney, L. J. L. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917.
2. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, et al. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921.
3. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, et al. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924.
4. Hilton, D. J., R. T. Richardson, W. S. Alexander, E. M. Viney, T. A. Willson, N. S. Sprigg, R. Starr, S. E. Nicholson, D. Metcalf, and N. A. Nicola, 1998. Twenty proteins containing a C-terminal SOCS box from five structural classes. Proc. Natl. Acad. Sci. USA 95:114.
5. Alexander, W. S. 2002. Suppressors of cytokine signalling (SOCS) in the immune system. Nature Rev. 2:1.
6. Greenhalgh, C. J., and D. J. Hilton. 2001. Negative regulation of cytokine signaling. J. Leukocyte Biol. 70:348.
7. Kubo, M., T. Hasana, and A. Yoshimura. 2003. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4:1169.
8. Mooney, R. A., J. Senn, S. Cameron, N. Inamdar, L. M. Boivin, Y. Shang, and R. W. Furlanetto. 2001, Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor, J. Biol. Chem. 276:25889.
9. Dey, B. R., R. W. Furnaletto, and P. Nissley. 2000. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochem. Biophys. Res. Comm. 278:38.
10. Eyckerman, S., D. Broekaert, A. Verhee, J. Vandekerckhove, J. Tavernier. 2000. Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor. FEBS Lett. 486:33.
11. Soriano, S. F., P. Hernanz-Falcon, J. M. Rodriguez-Frade, A. Martin de Ana, R. Garzon, C. Carvalho-Pinto, A. J. Vila-Coro, A. Zaballos, D. Balomenos, C. Martinez-A, and M. Mellado. 2002. Functional inactivation of CXC chemokine receptor 4-mediated responses through SOCS3 up-regulation. J. Exp. Med 196:311.
12. Cohney, S. J., D. Sanden, N. A. Cacalano, A. Yoshimura, A. Mui, T. S. Migone, and J. A. Johnston. 1999. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol. Cell. Biol. 19:4980.
13. Cacalano, N. A., D. Sanden, and J. A. Johnston. 2001. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nature Cell Biol. 3, 460.
14. De Sepulveda, P., K. Okkenhaug, J. La Rose, R. G. Hawley, P. Dubreuil, and R. Rottapel. 1999. Socs1 binds to multiple signaling proteins and suppresses Steel factor-dependent proliferation. EMBO J. 18:904.
15. Ohya, K., S. Kajigaya, Y. Yamashita, A. Miyazato, K. Hatake, Y. Miura, U. Ikeda, K. Shimada, K. Ozawa, and H. Mano. 1997. SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase. J. Biol. Chem. 272:27178.
16. Matsuda, T., T. Yamamoto, H. Kishi, A. Yoshimura, and A. Muraguchi. 2000. SOCS-1 can suppress CD3ζ- and Syk-mediated NF-AT activation in a non-lymphoid cell line. FEBS Lett. 472:235.
17. Ravetch, J., and S, Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19:275.
18. Mano, H. 1999. Tec family of protein-tyrosine kinases: an overview of their structure and function. Cytokine Growth Factor Rev. 10:267.
19. Banerjee, A., A. S. Banks, M. C. Nawijin, X. P. Chen, and P. B. Rothman. 2002. Suppressor of cytokine signaling 3 inhibits activation of NFATp. J. Immunol. 168:4277.
20. Suzuki, A., T. Hanada, K. Mitsuyama, T. Yoshida, S. Kamizono, T. Hoshino, M. Kubo, A. Yamashita, M. Okabe, K. Takeda, et al. 2001. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193:471.
21. Egan, P. J., K. E. Lawlor, W. S. Alexander, and J. P. Wicks. 2003. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J. Clin. Invest. 111:915.
22. Shouda, T., T. Yoshida, T. Hanada, T. Wakioka, M. Oishi, K. Miyoshi, K. Setsuro, K. Kosai, Y. Hanakawa, K. Hashimoto, K. Nagata, and A. Yoshimura. 2001. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J. Clin. Invest. 108:1781.
23. Diamond, P., P. Doran, H. R. Brady, and A. McGinty. 2000. Suppressors of cytokine signalling (SOCS): putative modulators of cytokine bioactivity in health and disease. J. Nephrol. 13:9.
24. Clynes, R., C. Dumitru, and J. V. Ravetch. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052.
25. Suzuki, Y., I. Shirato, K. Okumura, J. V. Ravetch, T. Takai, Y. Tomino, and C. Ra. 1998. Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int. 54:1166.
26. Park, S. Y., S. Ueda, H. Ohno, Y. Hamano, M. Tanaka, T. Shiratori, T. Yamazaki, H. Arase, N. Arase, A. Karasawa, et al. 1998. Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J. Clin. Invest. 102:1229.
27. Hora, K., J. A. Satriano, A. Santiago, T. Mori, E. R. Stanley, Z. Shan, and D. Schlondorff. 1992. Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony stimulating factor 1. Proc. Natl. Acad. Sci. USA 89:1745.
28. Gomez-Guerrero, C., M. J. Lopez-Armada, E. Gonzalez, and J. Egido. 1994. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-α and IL-6, and proliferation. J. Immunol. 153:5247.
29. Gómez-Guerrero, C., N. Duque, M. T. Casado, C. Pastor, J. Blanco, F. Mampaso, F. Vivanco, and J. Egido. 2000. Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex nephritis. J. Immunol. 164:2092.
30. 2+ mobilization in rat and human mesangial cells. J. Immunol. 156:4369.
31. Gomez-Guerrero, C., O. Lopez-Franco, Y. Suzuki, G. Sanjuan, P. Hernandez-Vargas, J. Blanco, and J. Egido. 2002. Nitric oxide production in renal cells by immune complexes: role of kinases and nuclear factor-κB Kidney Int. 62:2022.
32. Lopez-Franco, O., Y. Suzuki, G. Sanjuan, J. Blanco, P. Hernandez-Vargas, Y. Yo, J. Kopp, J. Egido, and C. Gomez-Guerrero. 2002. Nuclear factor-κB inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am. J. Pathol. 16:1497.
33. 4, is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol. 13:1657.
34. Saura, M., C. Zaragoza, M. Diaz-Cazorla, O. Hernandez-Perera, E. Eng, C. J. Lowenstein, D. Perez-Sala, and S. Lamas. 1998. Involvement of transcriptional mechanisms in the inhibition of NOS2 expression by dexamethasone in rat mesangial cells. Kidney Int. 53:38.
35. Duval, D., B. Reinhardt, C. Kedinger, and H. Boeuf. 2000. Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF)-dependent embryonic stem cell survival. FASEB J. 14:1577.
36. Saharinen, P., N. Ekman, K. Sarvas, P. Parker, K. Alitalo, and O. Silvennoinen. 1997. The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cδ. Blood 90:4341.
37. Bartoe, J. L., and N. M. Nathanson. 2002. Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor. Mol. Brain Res. 107:108.
38. Yasukawa, H., M. Hoshijima, Y. Gu, T. Nakamura, S. Pradervand, T. Hanada, Y. Hanakawa, A. Yoshimura, J. Ross, and K. R. Chien. 2001. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J. Clin. Invest. 108:1459.
39. Tsai, Y., Y. Su, S. Fang, T. Huang, Y. Qiu, Y. Jou, H. Shih, H. Kung, R. Chen. 2000. Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activatin. Mol. Cell. Biol. 20:2043.
40. Crespo, A., M. B. Filla, and W. J. Murphy. 2002. Low responsiveness to IFN-γ, after pretreatment of mouse macrophages with lipopolysaccharides, develops via diverse regulatory pathways. Eur. J. Immunol. 32:710.
41. Stoiber, D., S. Stockinger, P. Steinlein, J. Kovarik, and T. Decker. 2001. Listeria monocytogenes modulates macrophage cytokine responses through STAT serine phosphorylation and the induction of suppressor of cytokine signaling 3. J. Immunol. 166:466.
42. Terstegen, L., P. Gatsios, J. G. Bode, F. Schaper, P. C. Heinrich, and L. Graeve. 2000. The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130. J. Biol. Chem. 275:18810.
43. Feldman, G. M., E. J. Chuang, and D. S. Finbloom. 1995. IgG immune complexes inhibit IFN-γ-induced transcription of the FcγRI gene in human monocytes by preventing the tyrosine phosphorylation of the p91(Stat1) transcription factor. J. Immunol. 154:318.
44. Ji, J. D., J. Tassiulas, K. H. Park-Min, A. Aydin, I. Mecklenbräuder, A. Tarakhovsky, L. Pricop, J. E. Salmon, and L. B. Ivashkiv. 2003. Inhibition of interleukin 10 signaling after Fc receptor ligation during rheumatoid arthritis. J. Exp. Med. 197:1573.
45. Yamasaki, K., Y. Hanakawa, S. Tokumaru, Y. Shirakata, K. Sayama, T. Hanada, A. Yoshimura, and K. Hashimoto. 2003. Suppressors of cytokine signaling I/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathways in normal human epidermal keratinocytes. J. Invest. Dermatol. 120:571.